Vitalis Ortho secures new funding for joint preservation technology
Published
Regenerative interventions for knee osteoarthritis are the primary focus of Vitalis Ortho Ltd, a medical device company based in Litlington. The firm develops surgically implantable devices that aim to preserve joints for younger patients. These products provide an alternative designed to delay or prevent the eventual need for total joint replacement surgery.
A seed funding round has provided the startup with £708.4k. This investment follows the company's incorporation in March 2025.
Official documentation was filed in June. The share allotment occurred in May.
Contact the editorial team at [email protected]